2025 ADA Standards Highlight CGM, GLP-1s, and Hydration
The American Diabetes Association's 2025 Standards of Care introduce new guidelines for diabetes management, including broader use of continuous glucose monitoring (CGM) for type 2 diabetes patients not on insulin, expanded use of GLP-1 receptor agonists for heart and kidney health, and management of metabolic dysfunction-associated liver disease. The guidelines also emphasize the importance of drinking water over sweetened beverages and continuing weight management therapies beyond initial weight loss. Additionally, they recommend screening for psychosocial issues and antibody-based screening for presymptomatic type 1 diabetes in at-risk individuals.